Loading…
Comment on “Sarcopenia and cardiovascular diseases: A systematic review and meta‐analysis” by Zuo et al
[...]the prevalence of sarcopenia in this study was 27/160 = 16.8%, which was consistent with Sasaki's original study. [...]we had re-analysed the data and found the pooled prevalence of sarcopenia was 34.9% (95% CI: 28.1–41.8%), which was similar with the original systematic review and meta-an...
Saved in:
Published in: | Journal of cachexia, sarcopenia and muscle sarcopenia and muscle, 2023-12, Vol.14 (6), p.2988-2990 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]the prevalence of sarcopenia in this study was 27/160 = 16.8%, which was consistent with Sasaki's original study. [...]we had re-analysed the data and found the pooled prevalence of sarcopenia was 34.9% (95% CI: 28.1–41.8%), which was similar with the original systematic review and meta-analysis. [...]we think the authors need to present the study design of each original studies in Table 1. The prevalence of some disease is generated from a cross-sectional study, whereas the incidence of some disease is generated from a prospective cohort study. [...]we think the authors need to provide this important information (study design) of each original study, given the item of inclusion and exclusion criteria consisted of cross-sectional or prospective cohort studies. |
---|---|
ISSN: | 2190-5991 2190-6009 |
DOI: | 10.1002/jcsm.13382 |